Jack Kron

Division of Cardiovascular Medicine, Oregon Health & Science University, United States of America

Jack Kron is Professor of Medicine and Director of the Electrophysiology Laboratory at the Department of Cardiology, Oregon Health & Science University.

His research interests lie in arrhythmia management, atrial fibrillation, implantible defibrillators and radiofrequency catheter ablation.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Cardiovascular Disorders > Arrhythmias, Electrophysiology & Pacing (since 14 November 2005)

All recent recommendations

• 3.0
  Survival trends in the United States following exercise-related sudden cardiac arrest in the youth: 2000-2006.
  Recommended by Jack Kron
  
• 3.0
  Vasovagal syncope in the older patient.
  Recommended by Jack Kron
  
• 3.0
  Complications associated with defibrillation threshold testing: the Canadian experience.
  Recommended by Jack Kron
  
• 3.0
  Radiofrequency current delivery via transseptal needle to facilitate septal puncture.
  Recommended by Jack Kron
  
• 3.0
  Long QT syndrome in children in the era of implantable defibrillators.
  Recommended by Jack Kron
  
• 3.0
  Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.
  Recommended by Jack Kron
  
• 6.0
  Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.
  Recommended by Jack Kron
  
• 3.0
  Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
  Recommended by Jack Kron
  
• 3.0
  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
  Recommended by Jack Kron
  
• 4.8
  Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
  Recommended by Christopher Kramer, Jack Kron
  
• 3.0
  Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter.
  Recommended by Jack Kron
  
• 3.0
  Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
  Recommended by Jack Kron
  
• 3.0
  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
  Recommended by Jack Kron